Edge Capital Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,178	Closed	-$309K	–	321
2023 Q1	$309K	Buy	+3,178	New	+$309K	0.02%	255